Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
EU AND MICROFUNCTION REFERENCES QLRT-2001-00135 Publications (full length): Saulnier D.M.A, Molenaar D., Kolida S., De Vos W., Gibson G.R Identification of prebiotic fructooligosaccharide metabolism in L. plantarum WCFS1 using microarray. (submitted). C. L. Vernazza, G. R. Gibson and R. A. Rastall. (2005) In vitro Fermentation of Chitosan Derivatives by Mixed Cultures of Human Faecal Bacteria. Carbohydrate Polymers 60 (4): 539-545. C. L. Vernazza, G. R. Gibson and R. A. Rastall. (2006) Prebiotic Preference, Acid and Bile Tolerance of Five Strains of Bifidobacterium. Journal of Applied Microbiology 100: 846-853. Claire L. Vernazza, Bodin Rabiu and Glenn R. Gibson. (2006) Human Colonic Microbiology and the Role of Dietary Intervention: Introduction to Prebiotics. In Prebiotics: Development and Application. Whiley Press, Oxford. (in press). Mäkeläinen, H., Tahvonen, R., Salminen, S. and Ouwehand, A.C. (2003) In vivo safety assessment of two Bifidobacterium longum strains. Microbiology and Immunology 47: 911-914. Gueimonde, M., Ouwehand, A.C. and Salminen, S. (2004) Safety of Probiotics. Scandinavian Journal of Nutrition 48:42-48. Derrien, M., Adawi, D., Ahrné, S., Jeppsson, B., Molin, G., Osman, N., Štšepetova, J., Vaughan, E.E., de Vos, W.M. and Ouwehand, A.C. (2004) The intestinal mucosa as a habitat of the intestinal microbiota and a target for probiotic function and safety. Microbial Ecology in Health and Disease 16:137-144. Ouwehand, A.C., Saxelin, M. and Salminen, S. (2004) Assessment of suggested virulence factors and related properties of clinical, faecal and dairy Bifidobacterium isolates. Bioscience and Microflora 23:37-42. 1 EU AND MICROFUNCTION REFERENCES QLRT-2001-00135 Ouwehand, A.C., Saxelin, M. and Salminen, S. (2004) Phenotypic differences between commercial Lactobacillus rhamnosus GG and L. rhamnosus strains recovered from blood. Clinical Infectious Diseases 39:1858-1860. Ouwehand, A.C., Vankerckhoven, V., Goossens, H., Huys, G. Swings, J. Vancanneyt, M. and Lähteenmäki, A. (2005) The safety of probiotics in foods in Europe and its’ legislation In: Goktepe, I., Juneja, V.K. and Ahmedna, M. (eds.) Probiotics in Food Safety and Human Health. Marcel Dekker, Inc., New York. Ouwehand, A.C., Frias, R. and Gueimonde, M. (2006) Assuring the continued safety of probiotics and dairy starters. Mikrobiologia in press. Pultz, N.J., Vesterlund, S., Ouwehand, A.C. and Donskey, C.J. (2006) Adhesion of vancomycin-resistant Enterococcus to human intestinal mucus. Curr. Microbiol 52: 221-224. Gueimonde, M., Frias, R., Salminen, S. and Ouwehand, A.C. The feeding of clinical lactobacillus isolates to healthy rats and rats with induced colitis. Submitted. OSMAN, N., ADAWI, D., AHRNE, S., JEPPSSON, B. & MOLIN, G. (2004). Modulation of the effect of dextran sulfate sodium-induced acute colitis by the administration of different probiotic strains of Lactobacillus and Bifidobacterium. Digestive Diseases and Sciences 42: 320-327. OSMAN, N., ADAWI, D., AHRNÉ, S. JEPPSSON, B. & MOLIN, G. (2005). Probiotic strains of Lactobacillus and Bifidobacterium affect differently the translocation and intestinal load of Enterobacteriaceae after D-galactosamine-induced liver injury in rats. Microbial Ecology in Health and Disease 17: 40-46. 2 EU AND MICROFUNCTION REFERENCES QLRT-2001-00135 Derrien, M., Vaughan, E.E., Plugge, C.M, de Vos, W.M. (2004). Akkermansia muciniphila, a novel human intestinal mucin-degrading bacterium. International Journal of Systematic Evolutionary Microbiology 54( 5): 1469-76. Te Biesebeke, R., Boesten, R., Klaassens, E.S., Booijink, C.C.G.M., de Vries, MC., Derrien, M., Cohen, D.P.A., Schuren, F., Vaughan, E.E., Kleerebezem, M., de Vos, W.M. (2004). Microbial functionality in the human gastrointestinal tract. Microbes and Environments. 19 (4): 276-280. Ouwehand, A.C., Derrien, M., de Vos, WM., Tiihonen, K., Rautonen, N. (2005). Prebiotics and other microbial substrates for gut functionality. Current Opinion in Biotechnology 16 : 212-217. Stsepetova, J., Sepp, E., Julge, K., Vaughan, EE., Mikelsaar, M., and de Vos, W.M. Molecular comparison of fecal microbiota and distribution of Bifidobacteria in allergic and non-allergic children on the basis of 16S rDNA analysis. Submitted. Songisepp, E., Kullisaar, T., Hütt, P., Elias, P., Brilene, T., Zilmer, M., Mikelsaar, M. (2004). A New Probiotic Cheese with Antioxidative and Antimicrobial Activity. Journal of Dairy Science 87: 2017-2023. Songisepp E., Kals J., Kullisaar T., Hütt P., Mändar R., Zilmer M., Mikelsaar M. (2005). Evaluation of the functional efficacy of an antioxidative probiotic in healthy volunteers. Nutrition Journal, 4: 22. Hütt, P., Shchepetova, J., Lõivukene, K., Kullisaar, T., Mikelsaar, M. (2006) Antagonistic activity of probiotic lactobacilli and bifidobacteria against enteroand uropathogens. Journal of Applied Microbiology 100: 1324-32. 3 EU AND MICROFUNCTION REFERENCES QLRT-2001-00135 Abstracts Saulnier D.M.A., Kolida S., Gibson G.R. 2004. The development of a synbiotic product. First European Nutrigenomics conference. Wageningen (The Netherlands). Saulnier D.M.A, Kolida S., Gibson G.R. 2005. The development of a synbiotic product. School of Food Bioscience Research Day. The University of Reading, UK. Saulnier D.M.A, Molenaar D., Kolida S., Gibson G.R. 2006. Identification of prebiotic fructooligosaccharides metabolism in L. plantarum WCFS1 using microarray. 158th Society for General Microbiology Meeting. University of Warwick, UK. CLAIRE VERNAZZA, THEA SCANTLEBURY-MANNING, ROBERT RASTALL & GLENN GIBSON (2003) Effect of chitosan and its oligosaccharide on gut microflora populations using classical microbiological and molecular methods. Society for General Microbiology 153rd Meeting. Manchester, UK Zoetendal, E. G., Booijink, C. C. G., M. Derrien,M, Smidt, H, Kleerebezem, M, and de Vos, W. M.. Functional Genomics of GI tract Bacteria. 19-22/09/2005. 20th Congress of the Spanish Society for Microbiology SEM2005. Cáceres. Spain Zoetendal E. G., Booijink C. C. G. M., Derrien M., Smidt H., Kleerebezem M, and de Vos W. M. Host-microbe interactions in the gastrointestinal tract. Workshop: Darmendag 2005. 03/11/2005. UM, Maastricht. Derrien, M., Ben-Amor K, Vaughan, E.E., de Vos, W.M. Validation of a 16S rRNA probe and quantification of Akkermansia muciniphila, a novel intestinal mucin degrading bacterium. Poster at the The Food, GI-tract Functionality and Human Health cluster PROEUHEALTH congress. 3nd Workshop, March 2 – 5, 2004, Sitges (Spain). 4 EU AND MICROFUNCTION REFERENCES QLRT-2001-00135 Derrien, M., Štšepetova J., Plugge, C.M., Vaughan, E.E., de Vos, W.M. Monitoring of mucin-degrading bacteria: Isolation of strain MucT. Poster at the 1st FEMS Congress of European Microbiologists. June 29- july 3, 2003, Ljubljana (Slovenia). Derrien, M., Vaughan, E.E., Plugge, C.M, de Vos, W.M. Isolation of a novel intestinal mucin-degrading bacteria. Poster at the The Food, GI-tract Functionality and Human Health cluster PROEUHEALTH congress. 2nd Workshop, March 2 – 5, 2003, Taormina (Italy). Derrien, M., Vaughan, E.E., Plugge, C.M, de Vos, W.M. Molecular ecology of mucin associated bacteria from the human gastrointestinal tract. Poster at the IUMS (International Union of Microbiological Societies) congress. The world of microbes, July 27– August 01, 2002, Paris (France) Hütt, P., Shchepetova, J., Lõivukene, K., Mikelsaar, M.Determination of antagonistic activities of different probiotics against pathogens 28.08 01.09.2005, 8th symposium on Lactic Acid Bacteria, Egmond aan Zee, The Netherlands Mikelsaar, M., Truusalu, K., Kullisaar, T., Naaber, P., Mikelsaar, R.-H., Zilmer, M.Effect of probiotic induced antioxidative response in experimental murine typhoid. XI International Congress of Bacteriology and Applied Microbiology, IUMS 2005, California, USA, July 2005 Songisepp, E., Kals, J., Hütt, P., Mändar, R., Mikelsaar, M. Impact of the probiotic L. fermentum ME-3 consumption with different formulations and daily doses on the fecal lactoflora, its composition and ME-3 fecal recovery. Symposium on Lactic Acid Bacteria, Egmond aan Zee, The Netherlands, August 28 to September 01, 2005 Kullisaar, T., Lukman, A., Zilmer, K., Vihalemm, T., Mikelsaar, M., Zilmer, M. Probiotic L. fermentum ME-3 may have impact on the rehabilitation quality of 5 EU AND MICROFUNCTION REFERENCES QLRT-2001-00135 elderly stroke patients18th International Congress of Nutrition, September 19-23, 2005, Durban, South Africa Zilmer, M., Songisepp, E., Kullisaar, T., Zilmer, K., Mikelsaar, M. Lactobacillus fermentum: probiotic and health characteristics essential for conception of functional food.18th International Congress of Nutrition, September 19-23, 2005, Durban, South Africa Vihalemm, T., Kullisaar, T., Songisepp, E., Kaur, S., Zilmer, M. Probiotic fermented goats' milk influences glutathione metabolism in blood and skin of atopic dermatitis patients.18th International Congress of Nutrition, September 1923, 2005, Durban, South Africa Scientific Workshop „Probiotics, prebiotics and synbiotics” between the Department of Biochemistry (Tartu University) and the Department of Neurochemistry and Neurotoxicology (Stockholm University), Tartu, June 2005. 6